IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses

British Journal of Dermatology

Volumn 161, Issue 2, 2009, Pages 306-312

  Feliciani, C ^a,b   Caldarola, G ^a,b   Kneisel, A ^a   Podstawa, E ^a   Pfutze M ^a   Pfutzner W ^a   Hertl, M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autoantibody; Epitope spreading; Pemphigoid; Pruritus

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CARRIER PROTEIN; COLLAGEN TYPE 17; CYTOSKELETON PROTEIN; DST PROTEIN, HUMAN; IMMUNOGLOBULIN G; NERVE PROTEIN; NONFIBRILLAR COLLAGEN;

AGED; ARTICLE; B LYMPHOCYTE; BULLOUS PEMPHIGOID; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MALE; PRURITUS; SKIN;

AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; B-LYMPHOCYTES; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MALE; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PRURITUS; SKIN;

EID: 73349108456     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09266.x     Document Type: Article

References (28)

1. Laffitte E, Borradori L. Bullous pemphigoid: clinical features, diagnostic markers, and immunopathogenic mechanisms. In: Autoimmune Diseases of the Skin (Hertl M, ed.), 2nd edn. New York: Springer- Verlag, 2005; 2.
2. Di Zenzo G, Marazza G, Borradori L. Bullous pemphigoid: physiopathology, clinical features and management. Adv Dermatol 2007; 23:257-88.
3. Strohal R, Rappersberger K, Pehamberger H et al. Nonbullous pemphigoid: prodrome of bullous pemphigoid or a distinct pemphigoid variant? J Am Acad Dermatol 1993; 29:293-9.
4. Ross JS, McKee PH, Smith NP et al. Unusual variants of pemphigoid: from pruritus to pemphigoid nodularis. J Cutan Pathol 1992; 3:212-16.
5. Lamb PM, Abell E, Tharp M et al. Prodromal phase of bullous pemphigoid. Int J Dermatol 2006; 45:209-14.
6. Giudice GJ, Emery DJ, Zelickson BD et al. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 1993; 151:5742-50.
7. Matsumura K, Amagai M, Nishikawa T et al. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 1996; 288:507-9.
8. Zillikens D, Rose PA, Balding SD et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol 1997; 109:573-9.
9. Liu Z, Diaz LA, Troy JL et al. A passive transfer model of the organspecific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993; 92:2480-8.
10. Nishie W, Sawamura D, Goto M et al. Humanization of autoantigen. Nat Med 2007; 3:378-83.
11. Thoma-Uszynski S, Uter W, Schwietzke S et al. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J Immunol 2006; 176:2015-23.
12. Schmidt E, Obe K, Broker EB et al. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000; 136:174-8.
13. Hofmann S, Thoma-Uszynski S, Hunziker T et al. Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH2- and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002; 119:1065-73.
14. Nakatani C, Muramatsu T, Shirai T. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins. Br J Dermatol 1998; 139:365-70.
15. Hachisuka H, Hurose K, Karashima T et al. Serum from normal elderly individuals contains anti-basement membrane zone antibodies. Arch Dermatol 1996; 132:1201-5.
16. Hofmann SC, Tamm K, Hertl M, Borradori L. Diagnostic value of an enzyme-linked immunosorbent assay using BP180 recombinant proteins in elderly patients with pruritic skin disorders. Br J Dermatol 2003; 149:910-12.
17. Thoma-Uszynski S, Uter W, Schwietzke S et al. BP230- and BP180- specific auto-antibodies in bullous pemphigoid. J Invest Dermatol 2004; 122:1413-22.
18. Hall RP III, Murray JC, McCord MM et al. Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid. J Invest Dermatol 1993; 101:9-14.
19. Kiss M, Husz S, Jánossy T et al. Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230. J Autoimmun 2005; 1:1-10.
20. Guo LL, Degenstein J, Dowling QC et al. Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 1995; 81:233-43.
21. Di Zenzo GF, Grosso M, Terracina F et al. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J Invest Dermatol 2004; 122:103-10.
22. Rieckhoff-Cantoni L, Bernard P, Didierjean L et al. Frequency of bullous pemphigoid-like antibodies as detected by Western immunoblot analysis in pruritic dermatoses. Arch Dermatol 1992; 128:791-4.
23. D'Amato D, Silverstein J, Zitelli J. The prodrome of bullous pemphigoid. Int J Dermatol 1988; 27:560-3.
24. Wever S, Rank C, Hornschuh B et al. Subacute prurigo as a clinical variant of bullous pemphigoid. Hautarzt 1995; 46:789-95.
25. Tamada Y, Yokochi K, Oshitani Y et al. Pemphigoid nodularis: a case with 230 kDa hemidesmosomes antigen associated with bullous pemphigoid antigen. J Dermatol 1995; 3:201-4.
26. Powell AM, Albert S, Gratian MJ et al. Pemphigoid nodularis (nonbullous): a clinicopathological study of five cases. Br J Dermatol 2002; 147:343-9.
27. Schmidt E, Sitaru C, Schubert B et al. Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoid. J Am Acad Dermatol 2002; 47:133-6.
28. Tashiro H, Arai H, Hashimoto T et al. Two case studies and analysis of autoantibodies before and after the development of generalized blistering. J Nippon Med Sch 2005; 72:60-5.